Carcinoma, Renal Cell × temsirolimus × Genitourinary × Clear all ADONIS
Completed
554 enrolled
Temsirolimus (Torisel) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)
Completed
1,050 enrolled 9 charts
Phase II Study of Alternating Sunitinib and Temsirolimus
Phase 2 Completed
37 enrolled 13 charts
Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC)
Phase 2 Completed
69 enrolled 15 charts
Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
Phase 2 Completed
361 enrolled 12 charts
Personalized Targeted Inhibitors Treatment in Renal Cell Cancer
Phase 2 Terminated
4 enrolled 3 charts
NivoPlus
Phase 1/2 Terminated
33 enrolled
Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma
Phase 2 Completed
41 enrolled 9 charts
Neo-adjuvant Temsirolimus in Patients With Advanced Renal Cell Carcinoma
Phase NA Completed
11 enrolled
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors
Phase 1 Completed
19 enrolled
Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)
Phase 1 Completed
180 enrolled
INTORACT
Phase 3 Completed
791 enrolled 11 charts
INHIBITOR: Retrospective Study Of Patients With Renal Cell Carcinoma And Mantle Cell Lymphoma Treated With Temsirolimus
Completed
243 enrolled 12 charts
Sunitinib Plus Temsirolimus in Patients With Renal Cell Cancer (RCC)
Phase 1 Completed
23 enrolled
Trebananib And Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Phase 1 Completed
21 enrolled
Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
18 enrolled
INTORSECT
Phase 3 Completed
512 enrolled 16 charts
I-NET
Phase 1 Completed
18 enrolled
Chemotherapy and Biological Therapy in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
Phase 1 Completed
Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma
Phase 1 Completed
28 enrolled
A Post Marketing Surveillance As Required By Philippine Food And Drug Administration
Withdrawn
TORAVA
Phase 2 Completed
160 enrolled
ARCC
Phase 3 Completed
626 enrolled 18 charts
Temsirolimus-RCC-imaging
Phase 2 Unknown
51 enrolled
A Phase 1b, Open-Label, Dose-Finding Study to Evaluate the Safety of Tivozanib (AV-951) in Combination With Temsirolimus in Subjects With Metastatic Renal Cell Carcinoma
Phase 1 Completed
28 enrolled